相关实验视频

Updated: Jan 8, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

轻度减轻-介导NK细胞膜修饰用于ROS扫除效率克服免疫抑制瘤微环境

Kyung Mu Noh¹, Jaewon Park¹, Sungjun Kim¹

¹Department of Chemical & Biochemical Engineering, Dongguk University, Seoul, Republic of Korea.

Biotechnology journal

|December 20, 2025

概括

这项研究设计了自然杀手 (NK) 细胞来清理固体瘤中的反应性氧物种 (ROS). 修改后的NK细胞在ROS丰富的瘤微环境中显示出增强的抗癌活性.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
生物技术是生物技术.

背景情况:

固体瘤具有具有高反应性氧物种 (ROS) 的瘤微环境 (TME),这些物种会损害免疫细胞的功能.
自然杀手 (NK) 细胞对于癌症免疫疗法至关重要,但它们的有效性因TME中的氧化应激而降低.
维持NK细胞氧化还原平衡对于ROS丰富的TME中有效的癌症免疫疗法至关重要.

研究的目的:

开发一种强化NK细胞氧化还原平衡的方法,以增强其抗癌活性.
研究ex vivo膜修饰在氧化应激条件下改善NK细胞功能的潜力.

主要方法:

通过引入表面醇组,使用tris(2-carboxyethyl) phosphine (TCEP) 进行ROS清理,改造NK细胞.
评估了工程NK细胞 (STR-NK) 中的ROS清除能力,细胞内ROS水平和细胞毒性相关的基因表达.
在ROS的存在下,评估了STR-NK细胞对固体瘤细胞的细胞毒性活性.

主要成果:

表面醇丰富的NK细胞 (STR-NK) 呈现出增加的膜醇和高效的细胞外ROS消除.
在氧化应激下,STR-NK细胞表现出衰减的细胞内ROS积累,并保留了与细胞毒性相关的基因表达.
工程NK细胞在ROS丰富的条件下对固体瘤细胞保持强大的细胞毒性.

结论:

一种简单,可扩展的ex vivo膜修饰方法可以提高NK细胞的氧化还原平衡和抗癌活性.
这一策略提供了一种有前途的方法,用于改善ROS丰富的固体TME中的NK细胞基础免疫疗法.
NK细胞的表面氧化还原调节是克服癌症中氧化应激诱导的免疫抑制的可行方法.

关键词:

在ROS清理垃圾.这就是TCEP.活体外膜修饰的改变自然杀手细胞是什么?氧化应激是一种氧化应激.氧化还原平衡的重氧化平衡.

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

相关概念视频

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.